Manipal Hospitals
| Índia | Turquia | Áustria | |
| Terapia de radiação para o cancro colorretal | de $3,200 | de $7,000 | de $12,000 |
| Quimioterapia para cancro da mama | de $3,500 | de $1,200 | de $15,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Cancro do fígado estádio 3. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Cancro do fígado estádio 3 e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Cancro do fígado estádio 3.
O Dr. Sridhar P.S. traz experiência especializada em radioterapia para câncer de fígado, com credenciais de instituições líderes.
O Dr. Borde realizou mais de 30.000 exames PET e tratou 1.000 pacientes com câncer de tireoide no HCG Manavata Cancer Centre.
A Dra. Shruti Kate é especializada no tratamento de câncer de fígado avançado, com experiência em imunoterapia e terapia metronômica do Tata Memorial Hospital.
A cirurgia e os transplantes de fígado para o câncer de fígado em estágio 3 são possíveis, mas altamente seletivos. A elegibilidade depende do tamanho do tumor, da invasão vascular e da função hepática. Os centros indianos utilizam terapias de redução de estágio (downstaging) para diminuir os tumores. Esse processo pode tornar pacientes anteriormente inelegíveis em candidatos à ressecção ou transplante.
Perspectiva do Especialista Bookimed: A Índia abriga alguns dos centros de transplante de maior volume do mundo, como o Global Hospital Chennai, com mais de 1.000 casos bem-sucedidos. Esse volume massivo permite que os cirurgiões indianos lidem com casos complexos de estágio 3 que centros menores poderiam considerar inoperáveis. O Dr. Mohamed Rela, do Rela Institute, é um líder global em transplantes de alta complexidade. Os pacientes devem buscar avaliações nesses centros especializados em transplantes, em vez de clínicas de oncologia geral.
Consenso dos Pacientes: Os pacientes observam que os médicos frequentemente priorizam a redução do tumor por meio de terapia sistêmica antes de discutir a cirurgia. Muitos enfatizam que uma segunda opinião de um cirurgião de transplante dedicado é vital para casos de estágio 3.
India has top liver cancer specialists at JCI and NABH-accredited facilities. These facilities specialise in complex hepatobiliary oncology. Leading experts, such as Prof. Mohammed Rela and Dr Raj Nagarkar, manage advanced Stage 3 cases. They use robotic surgery, targeted therapies, and high-volume liver transplant programmes in Chennai, Delhi, and Gurgaon.
Bookimed Expert Insight: Data shows a clear distinction between multispecialty networks and dedicated cancer centres in India. Manipal Hospitals serves 2 million patients across 56 specialties. In contrast, centres like HCG Manavata focus solely on oncology with US-FDA audited research units. For Stage 3 cases, choosing these high-volume oncology hubs often provides access to TomoTherapy-H and Versa HD units. These units are not found in general hospitals.
Patient Consensus: Patients suggest consulting a hepatologist first. This consultation confirms the diagnosis before seeing an oncologist in India. They recommend prioritising curative options like resection or Y90 radiotherapy over palliative care. They also advise checking if VIP transfers and meals are included in private hospital packages.
In India, Stage 3 liver cancer treatment has roughly a 10% 4-year survival rate. Multidisciplinary protocols make this possible. Leading JCI-accredited hospitals use downstaging techniques like TACE and TARE to shrink tumours. This strategy turns advanced cases into candidates for curative surgery or organ transplants.
Bookimed Expert Insight: Indian liver centres like Apollo and Global Hospital function as high-volume hubs. They perform over 900 transplants annually. This massive case density allows Indian teams to accept complex Stage 3 cases. Such cases might be deemed inoperable elsewhere. Some facilities even offer combined liver-spinal or liver-kidney transplants for advanced patients.
Patient Consensus: Patients emphasise seeing a specialist liver surgeon first. They often find surgical options that general oncologists might overlook. Patients treated in India agree: confirm Y-90 or TACE treatment availability before travelling. This is vital for success.
Indian oncology centres offer curative pathways for stage 3 liver cancer through advanced downstaging protocols. While traditionally difficult to treat, specialists use TACE or radioembolisation (Y-90) to shrink tumours. This may help patients meet Milan criteria for life-saving liver transplants or surgical resections.
Bookimed Expert Insight: India excels in 'split liver' and minimally invasive transplants, which are critical for complex cases. Global Hospital Chennai has completed over 1,000 successful liver transplants. This high volume allows surgeons to accept complex stage 3 cases. These might be deemed inoperable elsewhere.
Patient Consensus: Remission is often possible if tumours shrink enough for surgery. Patients suggest getting a multidisciplinary team to review scans for downstaging eligibility in India.
Liver transplant eligibility for Stage 3 liver cancer in India requires meeting strict criteria. These include the Milan or UCSF benchmarks. Specialists at JCI-accredited centres like Apollo Hospital Indraprastha evaluate tumour size and number. They also check for vascular invasion. Treatment may include downstaging therapies to shrink tumours before surgery.
Bookimed Expert Insight: Indian clinics often accept advanced cases that Western hospitals might decline. Global Hospital Chennai reports a 95% five-year survival rate for liver transplants. Patients should check if clinics offer living donor transplants. This is vital as deceased donor waitlists in India often exceed one year.
Patient Consensus: Patients recommend getting three independent opinions from hepatologists to confirm the diagnosis. In India, people note the importance of finding a compatible living donor quickly. This prevents tumour progression.
Indian oncology centres manage Stage 3 liver cancer using locoregional therapies, targeted drugs, and immunotherapy. Specialists at JCI-accredited facilities like Apollo Hospital Indraprastha use TrueBeam STx and robotic systems to target tumours. Most protocols focus on downstaging tumours to enable potentially life-saving transplantation or resection.
Bookimed Expert Insight: Indian clinics offer a notable advantage in surgical volume for complex liver cases. At Global Hospital Chennai, surgeons maintain a 95% five-year survival rate for liver transplants. This high level of experience comes from over 1,000 successful transplants. It often makes them more willing to evaluate Stage 3 cases that other regions might deem inoperable.
Patient Consensus: Patients emphasise seeing a hepatobiliary surgeon rather than just a general oncologist. This helps check for curative surgery options. Many note that therapies like Y-90 or SBRT in India can effectively shrink tumours. This can make them eligible for a transplant.